The primary components of LNP–RNA are ionizable lipids, cholesterol, PEGylated lipids, and phospholipids, which together form the nanoparticle, along with the active pharmaceutical ingredient, RNA.
LNP–mRNA drug products are produced by mixing the nucleic acid drug substance with various lipid components, such as phospholipids, cholesterol, PEG–lipids and ionizable lipids, resulting in a ...
Particle Works offers a range of automated microfluidic systems that ensure robust laboratory processes and easy control of microfluidic parameters. Automated LNP formulation enables rapid and precise ...
The MarketWatch News Department was not involved in the creation of this content. Setting a New Benchmark in Precision and Efficiency for LNP Analysis SAN DIEGO, CALIFORNIA / ACCESS Newswire / March ...
CAMBRIDGESHIRE, UK, February 23, 2023 / EINPresswire.com / -- Particle Works, a leading provider of game-changing microfluidic nanoparticle synthesis platforms, is collaborating with NanoVation ...
Shin-Etsu Chemical Co., Ltd. (Head Office: Tokyo; President: Yasuhiko Saitoh; hereinafter, “Shin-Etsu Chemical”) and Hokkaido University (Location: Hokkaido ...
Earli is using Particle Works’ ALiS and ANP System to accelerate and optimize DNA-LNP formulation screening for potential cancer. The team at Earli is looking forward to using its new Particle Works ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback